Published in Vasc Health Risk Manag on December 02, 2015
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Adherence to medication. N Engl J Med (2005) 39.77
Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA (2005) 23.44
A new initiative on precision medicine. N Engl J Med (2015) 16.03
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2008) 11.07
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract (2005) 8.07
A randomized trial of genotype-guided dosing of warfarin. N Engl J Med (2013) 7.18
Measuring the global burden of disease. N Engl J Med (2013) 5.84
Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev (2001) 4.94
Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med (2007) 4.92
Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med (2005) 4.85
A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res (2013) 4.78
Drug metabolism and variability among patients in drug response. N Engl J Med (2005) 4.65
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation (2009) 3.39
Shared decision making: what do clinicians need to know and why should they bother? Med J Aust (2014) 3.14
Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev (2004) 3.07
Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med (2007) 3.06
Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ (2003) 3.05
Motivational interviewing for smoking cessation. Cochrane Database Syst Rev (2010) 2.60
The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18
Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart (2007) 1.91
Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev (2006) 1.89
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J (2013) 1.87
[Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert)]. Aten Primaria (2004) 1.79
Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. Arch Intern Med (1995) 1.72
Facilitating treatment adherence with lifestyle changes in diabetes. Am Fam Physician (2004) 1.69
Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke (2011) 1.64
Secondary preventive medication persistence and adherence 1 year after stroke. Neurology (2011) 1.62
What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics (2013) 1.41
Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation (2012) 1.34
Service organisation for the secondary prevention of ischaemic heart disease in primary care. Cochrane Database Syst Rev (2010) 1.31
Persistence with stroke prevention medications 3 months after hospitalization. Arch Neurol (2010) 1.31
Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J (2012) 1.30
A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease. Eur J Cardiovasc Prev Rehabil (2010) 1.28
Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study. BMC Public Health (2010) 1.16
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke (2012) 1.15
Cluster randomized controlled trial of a patient and general practitioner intervention to improve the management of multiple risk factors after stroke: stop stroke. Stroke (2010) 1.07
Interventions in the management of serum lipids for preventing stroke recurrence. Cochrane Database Syst Rev (2009) 1.06
Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol (2010) 1.06
Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis. Int Arch Med (2009) 1.05
Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry (1999) 1.04
Interventions for improving modifiable risk factor control in the secondary prevention of stroke. Cochrane Database Syst Rev (2014) 1.02
Antihypertensive drug use and adherence after stroke: are there sex differences? Stroke (2010) 1.02
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. Eur Heart J (2013) 1.01
Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events. Eur J Prev Cardiol (2012) 0.99
The impact of stroke nurse specialist input on risk factor modification: a randomised controlled trial. Age Ageing (2005) 0.98
Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst Rev (2004) 0.95
Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals? Stroke (2009) 0.94
Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial. Int J Cardiol (2007) 0.94
Quality of care in stroke prevention: results of an audit study among general practitioners. Prev Med (2004) 0.93
The association between patients' beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey. BMJ Open (2013) 0.90
Stroke genetics: prospects for personalized medicine. BMC Med (2012) 0.90
General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study. BMJ Open (2014) 0.89
Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. Neurology (2012) 0.88
Integrated care improves risk-factor modification after stroke: initial results of the Integrated Care for the Reduction of Secondary Stroke model. J Neurol Neurosurg Psychiatry (2008) 0.87
Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk. J Neurol Neurosurg Psychiatry (2008) 0.86
A new paradigm for primary prevention strategy in people with elevated risk of stroke. Int J Stroke (2014) 0.86
Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey. Eur J Prev Cardiol (2014) 0.86
Adherence to hospital discharge medication in patients with ischemic stroke: a prospective, interventional 2-phase study. Stroke (2012) 0.84
Health education in patients with a recent stroke or transient ischaemic attack: a comprehensive review. Int J Stroke (2011) 0.83
The caregiver role in thromboprophylaxis management in atrial fibrillation: a literature review. Eur J Cardiovasc Nurs (2014) 0.83
Utility of a post-hospitalization stroke prevention program managed by nurses. Hosp Pract (1995) (2013) 0.83
A randomized trial testing the superiority of a postdischarge care management model for stroke survivors. J Stroke Cerebrovasc Dis (2009) 0.82
Anticoagulant therapy for patients with ischaemic stroke. Nat Rev Neurol (2012) 0.82
Understanding long-term unmet needs in Australian survivors of stroke. Int J Stroke (2014) 0.82
Motivational interviewing techniques - facilitating behaviour change in the general practice setting. Aust Fam Physician (2012) 0.81
Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice. Int J Stroke (2011) 0.81
Risk factor management in survivors of stroke: a double-blind, cluster-randomized, controlled trial. Int J Stroke (2012) 0.79
Organized blood pressure control programs to prevent stroke in Australia: would they be cost-effective? Stroke (2012) 0.77
Computer-based clinical decision support for general practitioners. Fam Pract (2014) 0.76